Outcomes following second allogeneic haematopoietic transplants using fludarabine-melphalan conditioning

Bone Marrow Transplant. 2014 Jun;49(6):852-3. doi: 10.1038/bmt.2014.23. Epub 2014 Mar 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Allografts
  • Disease-Free Survival
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Male
  • Melphalan / administration & dosage*
  • Middle Aged
  • Myeloablative Agonists / administration & dosage
  • Transplantation Conditioning / methods
  • Treatment Outcome
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives*
  • Young Adult

Substances

  • Myeloablative Agonists
  • Vidarabine
  • fludarabine
  • Melphalan